How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

18,224 results for

"grant funding" or "obtaining grants" or "getting grants" or "grant awards" or (grants and "how to")

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

17841. Smokers' Health Project: Self-Determination and Maintaining Tobacco Abstinence

intervention (4 counselor visits over 6 months) increased cessation at 6 months relative to community care, and was also effective in increasing 12 month prolonged abstinence, and the results have been reported in two manuscripts (Williams, McGregor, Sharp, Levesque, Kouides, Ryan, and Deci, In press; Williams, McGregor, Sharp, Levesque, Kouides, Ryan, and Deci, 2005). The part of this first project that will be conducted as part of this grant will be to complete 32 month follow-up of smokers (...) during the additional 6 months focusing on maintenance and relapse prevention. Second, at least one family member or best friend of each patient will be encouraged to meet with a counselor to learn how to be more autonomy supportive with the patient around issues related to tobacco. Cessation and maintained abstinence will be examined with logistic regression. The SDT process model of maintained cessation will be tested using structural equation modeling, and cost-effectiveness analyses will be done

2005 Clinical Trials

17842. Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis

the same. The study is a next step to our completed FDA Orphan Product Development Grant funded study (FD-R-001686) that evaluated safety and efficacy of NO used for 4 hrs for treatment of vaso-occlusive crisis in pediatric patients with sickle cell disease. Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 18 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Quadruple (Participant, Care Provider (...) for investigator information Principal Investigator: Debra Weiner, MD, PhD Boston Children’s Hospital More Information Go to Publications: Layout table for additonal information Responsible Party: Debra Weiner, Assistant Professor of Pediatrics, Harvard Medical School, Boston Children’s Hospital ClinicalTrials.gov Identifier: Other Study ID Numbers: 04-09-119 FD-R-002560-01 ( Other Grant/Funding Number: FDA ) First Posted: September 2, 2005 Last Update Posted: July 19, 2017 Last Verified: July 2014 Keywords

2005 Clinical Trials

17843. Novel Strategies for Reducing Heart Disease Risk Disparities

ClinicalTrials.gov Identifier: Other Study ID Numbers: 0301102 PA DOH ME-02-384 ( Other Grant/Funding Number: Commonwealth of Pennsylvania ) First Posted: September 2, 2005 Last Update Posted: May 4, 2018 Last Verified: May 2018 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No Layout table for additional information Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No Keywords provided by Steven E. Reis, MD, University of Pittsburgh

2005 Clinical Trials

17844. Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination

before transplant may boost the recipient's immune response to the vaccine after transplant. This study is done to compare how vaccinating the donor with one of the vaccines will affect the recipient's immune system response to the vaccine. Condition or disease Intervention/treatment Phase Bone Marrow Transplant Biological: The polysaccharide vaccine used is Pneumovax (Merck vaccines) Biological: The conjugate vaccine used is Prevnar (Wyeth-Ayerst vaccines) Phase 4 Detailed Description (...) , Toronto The Physicians' Services Incorporated Foundation Investigators Layout table for investigator information Principal Investigator: Deepali Kumar, BSc, MSc, MD, FRCP(C) University Health Network, Toronto More Information Go to Layout table for additonal information ClinicalTrials.gov Identifier: Other Study ID Numbers: 02-0182-C P.S.I. Grant No. 02-67 First Posted: September 2, 2005 Last Update Posted: April 16, 2008 Last Verified: August 2005 Keywords provided by University Health Network

2005 Clinical Trials

17845. Obesity and Weight Loss on Reproductive Function

and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00143078 Recruitment Status : Terminated (Close-out of the grant - study ceased on 1/1/2010) First Posted : September 2, 2005 Last Update Posted : November 16, 2015 Sponsor: Milton S. Hershey Medical Center Collaborator: Tobacco Settlement Grant Information provided (...) by (Responsible Party): Richard S. Legro, M.D., Milton S. Hershey Medical Center Study Details Study Description Go to Brief Summary: The purpose of this study is to examine how obesity and weight loss following bariatric surgery affect reproductive function. The study is particularly interested in how changes in hormones (those produced in the stomach and fat tissue) following weight loss affect reproductive function. Specifically, we, the researchers at Penn State University, propose to characterize

2005 Clinical Trials

17846. Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disorders

and Collaborators Bavarian Nordic National Institute of Allergy and Infectious Diseases (NIAID) Investigators Layout table for investigator information Principal Investigator: Frank von Sonnenburg, M.D. Department of Infectious Diseases and Tropical Medicine of the University of Munich More Information Go to Publications of Results: Layout table for additonal information Responsible Party: Bavarian Nordic ClinicalTrials.gov Identifier: Other Study ID Numbers: POX-MVA-007 N01-AI-30016 ( Other Grant/Funding

2005 Clinical Trials

17847. Caffeine for Apnea of Prematurity (CAP)

by ClinicalTrials.gov Identifier (NCT Number): Layout table for additonal information Responsible Party: McMaster University ClinicalTrials.gov Identifier: Other Study ID Numbers: CTMG-1999-CAP ISRCTN44364365 ( Registry Identifier: Current Controlled Trials ) MCT-13288 ( Other Grant/Funding Number: CIHR ) MOP-102601 ( Other Grant/Funding Number: CIHR ) First Posted: September 16, 2005 Last Update Posted: March 22, 2018 Last Verified: September 2016 Keywords provided by McMaster University: preterm infants very low

2005 Clinical Trials

17848. A Study of Sertraline to Prevent PTSD

: Frederick J. Stoddard, MD, Principal Investigator, Massachusetts General Hospital ClinicalTrials.gov Identifier: Other Study ID Numbers: SHC Grant No. 8840 SHC Grant No. 8840 ( Other Grant/Funding Number: Shriners Hospitals for Children ) Protocol #:2002P001521; MGH ( Other Identifier: Partners Human Research Committee ) First Posted: September 16, 2005 Results First Posted: August 5, 2014 Last Update Posted: August 5, 2014 Last Verified: July 2014 Keywords provided by Frederick J. Stoddard, MD

2005 Clinical Trials

17849. Increasing Physical Activity Among Overweight Women With Mobility Disabilities.

( Other Grant/Funding Number: CDC/NCBDDD/DHDD ) First Posted: September 14, 2005 Last Update Posted: July 28, 2011 Last Verified: July 2011 Keywords provided by Centers for Disease Control and Prevention: obesity, mobility limitations, women, physical activity Additional relevant MeSH terms: Layout table for MeSH terms Overweight Mobility Limitation Body Weight Signs and Symptoms

2005 Clinical Trials

17850. Breastfeeding, Antiretroviral, and Nutrition Study

Identifier (NCT Number): Layout table for additonal information Responsible Party: Dr. Denise Jamieson, CDC ClinicalTrials.gov Identifier: Other Study ID Numbers: CDC-NCCDPHP-3946 U48CCU409660 ( Other Grant/Funding Number: U.S. Centers for Disease Control and Prevention ) PA 04003 SIP 26-04 ( Other Grant/Funding Number: U.S. Centers for Disease Control and Prevention ) First Posted: September 14, 2005 Last Update Posted: April 23, 2010 Last Verified: April 2010 Keywords provided by Centers for Disease

2005 Clinical Trials

17851. A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum

Peter MacCallum Cancer Centre, Australia More Information Go to Additional Information: Publications: Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number): Layout table for additonal information Responsible Party: Trans-Tasman Radiation Oncology Group (TROG) ClinicalTrials.gov Identifier: Other Study ID Numbers: TROG 01.04 NHMRC 209123 ( Other Grant/Funding Number: National Health Medical and Research Council ) First Posted: September 5, 2005 Last Update

2005 Clinical Trials

17852. Texture Analysis for Postmenopausal Osteoporosis

morphology. Advances in Electronics and Electron Physics, 1994. 88: p. 199-246. Layout table for additonal information Responsible Party: University of Chicago ClinicalTrials.gov Identifier: Other Study ID Numbers: IRB# 11009B NIH AR42739 ( Other Grant/Funding Number: NIH ) NIH AR42739-S1 ( Other Grant/Funding Number: NIH ) First Posted: September 5, 2005 Results First Posted: September 11, 2018 Last Update Posted: September 11, 2018 Last Verified: August 2018 Individual Participant Data (IPD) Sharing

2005 Clinical Trials

17853. Costs and Effects of Three Modes for Disease Management of Chronic Obstructive Pulmonary Disease in General Practice

, Nijmegen, The Netherlands Principal Investigator: Erik Bischoff, MD Department of General Practice, Radboud University, Nijmegen, The Netherlands More Information Go to Publications: Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number): Layout table for additonal information Responsible Party: E. Bischoff, MD MSc, Radboud University ClinicalTrials.gov Identifier: Other Study ID Numbers: MONC95582 ZonMw grant: 945.04.230 ( Other Grant/Funding Number: ZonMw (...) ) Picasso grant: 005.2004 ( Other Grant/Funding Number: Picasso ) CMO: 2004/249 ( Other Identifier: Medical Ethics Committee ) First Posted: August 10, 2005 Last Update Posted: November 22, 2011 Last Verified: November 2011 Keywords provided by E. Bischoff, Radboud University: chronic obstructive pulmonary disease (COPD) self-management practice nurse cost-effectiveness randomized controlled trial Additional relevant MeSH terms: Layout table for MeSH terms Lung Diseases Lung Diseases, Obstructive

2005 Clinical Trials

17854. Adherence to Guidelines for Antibiotic Use in Respiratory Infections at Hospitals

Measures : adherence to key quality indicators for antibiotic use in lower respiratory tract infections (indicators were developed from current [inter]national guideline recommendations and a systematic review of the literature) Secondary Outcome Measures : cost process evaluation: how well was the intervention performed length of hospital stay in-hospital mortality Intensive Care Unit (ICU)-transfer 30 day re-admission rate Eligibility Criteria Go to Information from the National Library of Medicine (...) ClinicalTrials.gov Identifier: Other Study ID Numbers: AGAR-2001-1 ZonMw grant no. 2300.0024 First Posted: August 12, 2005 Last Update Posted: September 27, 2005 Last Verified: August 2002 Keywords provided by Radboud University: quality of care antibiotic use intervention lower respiratory tract infections Community acquired Pneumonia Acute Exacerbation of Chronic Bronchitis or COPD Additional relevant MeSH terms: Layout table for MeSH terms Pneumonia Bronchitis Bronchitis, Chronic Lung Diseases Respiratory

2005 Clinical Trials

17855. HOME Study (Health Outcomes and Measures of the Environment Study)

: Publications of Results: Other Publications: Bowers K, Khoury J, Sucharew H, Xu Y, Chen A, Lanphear B, Yolton K. Early infant attention as a predictor of social and communicative behavior in childhood. International Journal of Behavioral Development 2018:0165025418797001. Layout table for additonal information Responsible Party: National Institute of Environmental Health Sciences (NIEHS) ClinicalTrials.gov Identifier: Other Study ID Numbers: 11261-CP-001 MDLTS0008-18 ( Other Grant/Funding Number: HUD

2005 Clinical Trials

17856. A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia

-A01 SMRI 03T-459 ( Other Grant/Funding Number: SMRI 03T-459 ) First Posted: May 29, 2008 Last Update Posted: July 12, 2016 Last Verified: July 2016 Keywords provided by Xiang Yang Zhang, Beijing HuiLongGuan Hospital: Schizophrenia clinical trial risperidone immune celecoxib Additional relevant MeSH terms: Layout table for MeSH terms Schizophrenia Schizophrenia Spectrum and Other Psychotic Disorders Mental Disorders Celecoxib Risperidone Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non

2006 Clinical Trials

17857. Heliox-Driven Racemic Epinephrine Nebulization in Treatment of Moderate to Severe Bronchiolitis in Pediatric ED Patients

of Louisville ClinicalTrials.gov Identifier: Other Study ID Numbers: GRNT040954 GRNT040954 G040954 ( Other Grant/Funding Number: Praxair Healthcare ) First Posted: June 30, 2005 Last Update Posted: June 18, 2013 Last Verified: June 2013 Keywords provided by University of Louisville: heliox bronchiolitis racemic epinephrine Additional relevant MeSH terms: Layout table for MeSH terms Bronchiolitis Bronchitis Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases Respiratory

2005 Clinical Trials

17858. Spinal Cord Stimulation to Restore Cough

Reserve University ClinicalTrials.gov Identifier: Other Study ID Numbers: IRB98-00091 IRB 98-00091 278855 ( Other Grant/Funding Number: Neilsen Foundation ) First Posted: June 29, 2005 Last Update Posted: February 1, 2018 Last Verified: January 2018 Keywords provided by Anthony F. DiMarco, MD, Case Western Reserve University: spinal cord injury paralysis cough cervical spinal cord injury thoracic spinal cord injury Additional relevant MeSH terms: Layout table for MeSH terms Wounds and Injuries Spinal

2005 Clinical Trials

17859. Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

ways may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving an hepatic arterial infusion of melphalan together with hepatic perfusion works in treating patients with unresectable liver cancer. Condition or disease Intervention/treatment Phase Cancer Drug: isolated perfusion Drug: melphalan Phase 2 Detailed Description: OBJECTIVES: Primary Determine the response rate and duration of response in patients with unresectable primary or metastatic liver cancer treated (...) To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00096083 Locations Layout table for location information United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Sponsors and Collaborators Delcath Systems Inc. National Cancer Institute (NCI

2004 Clinical Trials

17860. Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

information Principal Investigator: Kelvin Lee, MD Roswell Park Cancer Institute More Information Go to Layout table for additonal information Responsible Party: Roswell Park Cancer Institute ClinicalTrials.gov Identifier: Other Study ID Numbers: CDR0000391767 RPCI-I-18103 ( Other Identifier: Roswell Park Cancer Institute ) CELGENE-RV-CLL-PI-005 ( Other Grant/Funding Number: Celgene ) First Posted: November 9, 2004 Results First Posted: July 11, 2017 Last Update Posted: July 11, 2017 Last Verified: June (...) or deliver cancer-killing substances to them without harming normal cells. Combining lenalidomide with rituximab may kill more cancer cells. PURPOSE: This phase II trial is studying the how well giving lenalidomide with or without rituximab works in treating patients with relapsed or refractory chronic lymphocytic leukemia. Condition or disease Intervention/treatment Phase Leukemia Biological: rituximab Drug: lenalidomide Phase 2 Detailed Description: OBJECTIVES: Primary Determine the best cytostatic

2004 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>